These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23583495)
1. Interdependency of protein-release completeness and polymer degradation in PLGA-based implants. Ghalanbor Z; Körber M; Bodmeier R Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):624-30. PubMed ID: 23583495 [TBL] [Abstract][Full Text] [Related]
2. Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: thioester formation as a reason for incomplete release. Ghalanbor Z; Körber M; Bodmeier R Int J Pharm; 2012 Nov; 438(1-2):302-6. PubMed ID: 22989984 [TBL] [Abstract][Full Text] [Related]
3. Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin. Duque L; Körber M; Bodmeier R Int J Pharm; 2018 Mar; 538(1-2):139-146. PubMed ID: 29355654 [TBL] [Abstract][Full Text] [Related]
4. Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants. Cossé A; König C; Lamprecht A; Wagner KG AAPS PharmSciTech; 2017 Jan; 18(1):15-26. PubMed ID: 27193002 [TBL] [Abstract][Full Text] [Related]
5. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor. Desai KG; Mallery SR; Schwendeman SP Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553 [TBL] [Abstract][Full Text] [Related]
6. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568 [TBL] [Abstract][Full Text] [Related]
8. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity. Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778 [TBL] [Abstract][Full Text] [Related]
9. Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery. Rajagopal K; Wood J; Tran B; Patapoff TW; Nivaggioli T J Pharm Sci; 2013 Aug; 102(8):2655-66. PubMed ID: 23754501 [TBL] [Abstract][Full Text] [Related]
10. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
11. Development of poly (lactic-co-glycolic acid) (PLGA) based implants using hot melt extrusion (HME) for sustained release of drugs: The impacts of PLGA's material characteristics. Yang F; Stahnke R; Lawal K; Mahnen C; Duffy P; Xu S; Durig T Int J Pharm; 2024 Sep; 663():124556. PubMed ID: 39122196 [TBL] [Abstract][Full Text] [Related]
12. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging. Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591 [TBL] [Abstract][Full Text] [Related]
13. BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. Estey T; Kang J; Schwendeman SP; Carpenter JF J Pharm Sci; 2006 Jul; 95(7):1626-39. PubMed ID: 16729268 [TBL] [Abstract][Full Text] [Related]
14. PLGA-based monolithic filaments prepared by hot-melt extrusion: In-vitro comparative study. Kamel R; Abbas H Ann Pharm Fr; 2018 Mar; 76(2):97-106. PubMed ID: 29145995 [TBL] [Abstract][Full Text] [Related]
15. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324 [TBL] [Abstract][Full Text] [Related]
16. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. Lee J; Oh YJ; Lee SK; Lee KY J Control Release; 2010 Aug; 146(1):61-7. PubMed ID: 20553775 [TBL] [Abstract][Full Text] [Related]
17. Sustained release of bovine serum albumin using implantable wafers prepared by MPEG-PLGA diblock copolymers. Kim MS; Seo KS; Hyun H; Kim SK; Khang G; Lee HB Int J Pharm; 2005 Nov; 304(1-2):165-77. PubMed ID: 16198075 [TBL] [Abstract][Full Text] [Related]
18. Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders. Kang J; Lambert O; Ausborn M; Schwendeman SP Int J Pharm; 2008 Jun; 357(1-2):235-43. PubMed ID: 18384984 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers. Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]